https://www.selleckchem.com/products/a1874.html
17) compared with no VitD supplementation. However, high-density lipoprotein cholesterol levels showed no differences with or without VitD supplementation (-0.39 mg/dL; 95% CI -1.39 to 0.61). VitD supplementation improved serum lipid levels among PCOS patients, but serum high-density lipoprotein cholesterol levels were not changed. VitD intervention might benefit PCOS patients who are at high risk of an atherogenic lipid profile. VitD supplementation improved serum lipid levels among PCOS patients, but serum high-density lipoprotein chole